The study the effect of intranasal and intravenous dexmeditomidine
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/09/057760
- Lead Sponsor
- Vardhman Mahavir Medical College New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Adult patients belonging to ASA grade I &II
2.Scheduled for elecytive surgery under general anaestheia.
Exclusion Criteria
1. Uncooperating, non consenting patients.
2. Known allery or hypersenstivity to dexmeditomidine.
3. Pregnant, lactating mothers, Cardiac or respratory disease, uncontrolled hypertension, diabetes mellitus type II, neurological or psychiatric disease, or any intranasal pathology{like nasal ulcers, polyps, nasaal septal deviation}.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean arterial pressure{MAP}Timepoint: 40 minutes before induction, 2 min before induction, 2,5,7,9 min after induction.
- Secondary Outcome Measures
Name Time Method Systolic blood pressure{SBP}, diastolic blood pressure{DBP} & heart rate.Timepoint: 40 minutes before induction, 2 min before induction, 2,5,7,9 min after induction.